Diagnostic value of immunohistochemistry in soft tissue tumors

  • Sridevi V Dept of Pathology, SriMuthukumaran Medical college and Hospital, Chennai
  • Susruthan Muralitharan Dept of Pathology, SriMuthukumaran Medical college and Hospital, Chennai
  • Thanka J Dept of Pathology, SriMuthukumaran Medical college and Hospital, Chennai
Keywords: Soft tissue tumors, immunohistochemistry markers, soft tissue sarcomas, diagnosis.

Abstract

Background: Diagnosis of soft tissue tumors is a great challenge to pathologist but with the help of immunohistochemistry (IHC), proper analysis and diagnosis of soft tissue tumours can be made easy. The main use of immunohistochemistry in soft tissue neoplasms especially in sarcomas is to identify differentiation in the neoplastic cells.IHC are used as a panel or as single marker depending on the tumor.  Materials and methods: A total of 513 soft tissue tumor (STT) cases were collected and reviewed. The cases were separated into as benign, intermediate and malignant cases. In 90 cases of STT in which immunohistochemistry (IHC) were used was further analysed and classified depending on the various positivity and negativity of the marker used .The significance of IHC was also analysed.Result: In our study of 513 cases of STT there were 380 benign cases, 90 malignant cases and 43 intermediate cases. A total of 90 cases of sarcomas were present out of which 54% cases required IHC, 20 % cases required IHC to support the diagnosis but 26% of cases did not require IHC, the diagnosis was made on haematoxylin and eosin (H&E). The IHC markers helped in correct diagnosis of STT cases.Conclusion: Immunohistochemistry plays an important role in grading and giving precise diagnosis of soft tissue tumors. So it is important to use IHC to diagnose STT where haematoxylin and eosin did not give a precise diagnosis. Perfect diagnosis of STT helps in the correct therapeutic management of patients.DOI: 10.21276/APALM.1637

Author Biographies

Sridevi V, Dept of Pathology, SriMuthukumaran Medical college and Hospital, Chennai
Assistant Professor, Department of Pathology,Sri Muthukumaran Medical College and Research Institute, Mangadu, Chennai, India.                  
Susruthan Muralitharan, Dept of Pathology, SriMuthukumaran Medical college and Hospital, Chennai
Asst. Professor, Department of Pathology,Sri Ramachandra medical college and Research institute,Porur, Chennai, India
Thanka J, Dept of Pathology, SriMuthukumaran Medical college and Hospital, Chennai
Professor, Department of Pathology,Sri Ramachandra medical college and Research institute,Porur, Chennai, India

References

1. Fisher C. Immunohistochemistry in Diagnosis of Soft Tissue Tumours. Histopathology. Wiley, 2010; 58 (7):1001.

2. Heim-Hall J, Yohe SL. Immunohistochemistry of Soft Tissue Neoplasms. ArchPathol Lab Med. 2008; 132:476-489.

3. Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2003; 43: 1-16.

4. Fisher C. The comparative roles of electron microscopy and immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2006;48:32-41.

5. Hornick JL. Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors. Modern Pathology. 2014; 27: 47–63.

6.Suster S. Recent advances in the application of Immunohistochemical markers for the diagnosis of soft tissue tumours. Semin. Diagn. Pathol. 2000; 17: 225-235.

7.de Saint N, Somerhausen A. Immunohistochemistry in the diagnosis of soft tissue tumors. Path 2005: 2-12.

8.Ceballos KM, Nielsen GP, Selig MK, O’ Connell JX. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Am. J. Clin. Pathol. 2000; 114: 746-753.

9.Yves-Marie Robin et al. Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors. Modern Pathology.2013; 26: 502–510

10. Kumar S, Perlman E, Harris CA et al. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin- embedded tissues. Mod. Pathol. 2000; 13: 988-993.

11. Dias P Chen B, Dilday B et al. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am. J. Pathol. 2000; 156: 399-408.

12.Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol. 2006;19:659–668.

13.Yang L et al.Clinical pathological analysis of synovial sarcoma.Chinese Journal of clinical oncology.2007;4:246-249.

14.Cunha KS et al. Evaluation of Bcl-2, Bcl-x and Cleaved Caspase-3 in Malignant Peripheral Nerve Sheath Tumors and Neurofibromas .Annals of the Brazilian Academy of Sciences. 2013 March.

15.Li N, McNiff J, Hui P, et al. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcomaprotuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. Am J Dermatopathol.2004;26:267–272.

16.Gupta, et al., Typing and Grading of Soft Tissue Tumors and their Correlation with Proliferative Marker Ki-67. J CytolHistol. 2015; 6:3.
Published
2017-12-22
Section
Original Article